Delivery Order SPE2DB20D3303-SPE2DB24FA1RA
Award Date
7/31/24
Potential Completion Date
8/1/24
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,975.54 contract is for the supply of PROLENSA 0.07% eye drops. The contract has a period of performance through May 6, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PROLENSA 0.07% eye drops, 3 mL, with a ceiling value of $1,500.69 and a completion date of June 24, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was made by the Medical Supply Chain division of the U.S. Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of PROLENSA 0.07% eye drops. The contract has a ceiling value of $1,025.79 and is a Firm Fixed Price Delivery Order with a completion date of July 11, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
This federal contract award, valued at $7,455.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4560410185 PROLENSA 0.07% eye drops, a specialty pharmaceutical product, with a period of performance through March 29, 2023. This delivery order is under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which...
This federal contract award, valued at $6,210.31, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of PROLENSA 0.07% eye drops, a pharmaceutical product, to support military treatment programs and facilities. The contract is a firm fixed price delivery order with a performance period through March 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is the...
This is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC), valued at up to $999,999,999 through December 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, which has been awarded a contract to supply a variety of prescription medications, over-the-counter drugs, and medical supplies to support military treatment programs and facilities worldwide. The specific item being delivered under...
This federal contract award is for the delivery of PROLENSA 0.07% eye drops (3ml) to the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense (DoD). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., on September 26, 2023, with a total ceiling value of $19,398.20 and a completion date of September 27, 2023. The contract is a delivery order with a firm fixed-price pricing type. This contract is not...
This federal contract award, valued at $2,564.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROLENSA 0.07% eye drops with an ultimate completion date of January 28, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside program and appears to be part of a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of PROLENSA 0.07% eye drops (3 mL). The $1,777.03 firm fixed-price delivery order does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,560,258,236 units of PROLENSA 0.07% eye drops. The Firm Fixed Price delivery order, valued at $4,319.98, has a period of performance through March 15, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...